Skip to main content

Table 1 Patients and disease characteristics (n=48)

From: The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

Age (year)

 

 32–80

(median 66)

Gender

 

 Male

40

 Female

8

Histology

 

 Clear cell

41

 Papillary

5

 HD*

1

 Clear/sarcomatoid

1

MSKCC classification

 

 Favorable

17

 Intermediate

24

 Poor

7

Nephrectomy

 

 Yes

38

 No

10

Prior systematic treatment

 

 Non

30

 Cytokine

14

 TKI

4

Evaluated RCC lesions

(total 190)

 Lung

49

 Bone

40

 Lymph node

37

 Abdominal organ

29

 Muscle/Soft tissue

26

 Primary

9

  1. HD*: mixed clear cell and papillary renal carcinoma in a hemodialysis patient.